Anavex Appoints Wolfgang Liedtke as Senior Vice President of Neurology.
ByAinvest
Thursday, Jan 8, 2026 7:36 am ET1min read
AVXL--
Anavex Life Sciences Corp. has appointed Wolfgang Liedtke, MD PhD, as Senior Vice President and Global Head of Neurology. Dr. Liedtke brings over 25 years of experience in developing and delivering innovative medicines for CNS diseases, including genetic medicines and global therapeutic development. He previously held the position of Chair of Neurology at Regeneron, overseeing 45 clinical trials, including 14 Phase 3 studies.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet